Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
orphan drug
Pharma
Vyvgart, Cabenuva, Lumakras top Trinity launch success analysis
Treatments for autoimmune diseases and those in orphan markets are on the up and up, according to Trinity Life Sciences’ annual Drug Index.
Andrea Park
Mar 12, 2025 2:13pm
Orphan drug market to reach $270B by 2028: Evaluate
Apr 24, 2024 12:01am
AZ challenges the IRA's 'unintended consequences' with lawsuit
Aug 25, 2023 11:26am
FDA signs off on Sanofi's rare disease drug Xenpozyme
Aug 31, 2022 3:18pm
Sanofi's Dupixent may soon snag a 4th immunology nod
Feb 28, 2022 10:59am
Catalyst one-ups Jacobus, FDA in Firdapse exclusivity appeal
Oct 1, 2021 12:11pm
